MegaPro Biomedical Co., Ltd (6827.TWO)
TWD 13.25
(-5.69%)
TWD 13.25
(-5.69%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 8.31 Million TWD | -23.89% |
| 2022 | 10.92 Million TWD | -18.82% |
| 2021 | 13.46 Million TWD | 0.0% |
| 2020 | - TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 2.84 Million TWD | -65.86% |
| 2023 FY | 8.31 Million TWD | -23.89% |
| 2023 Q2 | 9.63 Million TWD | -11.86% |
| 2023 Q4 | 8.31 Million TWD | -13.65% |
| 2022 Q4 | 10.92 Million TWD | 0.0% |
| 2022 FY | 10.92 Million TWD | -18.82% |
| 2021 FY | 13.46 Million TWD | 0.0% |
| 2020 FY | - TWD | 0.0% |
| 2019 FY | - TWD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Bio Preventive Medicine Corp. | 113.44 Million TWD | 92.668% |
| Genomics BioSci & Tech. Co.,Ltd. | 283.61 Million TWD | 97.067% |
| Advagene Biopharma Co., Ltd. | 870 Thousand TWD | -856.092% |
| Taiwan Bio Therapeutics Co., Ltd | 268.62 Million TWD | 96.903% |
| NaviFUS Corp. | 32.69 Million TWD | 74.557% |
| G&E Herbal Biotechnology Co., Ltd. | 5.43 Million TWD | -53.158% |
| TaiRx, Inc. | 12.28 Million TWD | 32.297% |
| Sinew Pharma Inc. | 6.46 Million TWD | -28.682% |
| Lin BioScience, Inc. | 42.87 Million TWD | 80.599% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 1.17 Million TWD | -610.333% |
| Lumosa Therapeutics Co., Ltd. | 12.61 Million TWD | 34.036% |
| Anti-Microbial Savior BioteQ Co., Ltd | 1.38 Million TWD | -501.446% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 402.75 Million TWD | 97.935% |
| AP Biosciences Inc | 82.07 Million TWD | 89.866% |
| Sunmax Biotechnology Co., Ltd. | 174.08 Million TWD | 95.222% |
| RBC Bioscience Corporation | 487.36 Million TWD | 98.293% |
| Syngen Biotech Co.,Ltd. | 681.76 Million TWD | 98.78% |
| EirGenix Inc. | 465.16 Million TWD | 98.212% |
| Enimmune corporation | 45.73 Million TWD | 81.812% |
| Lukas Biomedical Inc. | 82.55 Million TWD | 89.924% |
| BRIM Biotechnology, Inc. | 3.59 Million TWD | -131.57% |
| 3D Global Biotech Inc. | 10.37 Million TWD | 19.857% |
| TaiMed Biologics Inc. | 750.85 Million TWD | 98.892% |
| Mycenax Biotech Inc. | 726.27 Million TWD | 98.855% |
| TCI GENE Inc. | 6.79 Million TWD | -22.414% |
| SynCore Biotechnology Co.,Ltd | 2.11 Million TWD | -293.472% |
| Oneness Biotech Co., Ltd. | 397.95 Million TWD | 97.91% |
| Eusol Biotech Co.,Ltd. | 4.35 Million TWD | -91.043% |
| Feng Chi Biotech Corp. | 10.79 Million TWD | 22.967% |
| NeoCore Technology Co., Ltd. | 96.89 Million TWD | 91.415% |
| TWi Biotechnology, Inc. | 7.97 Million TWD | -4.353% |
| Neith Corporation | 3.54 Million TWD | -134.905% |
| Sunny Pharmtech Inc. | 391.42 Million TWD | 97.875% |
| VBI | - TWD | -Infinity% |
| Ever Supreme Bio Technology Co., Ltd | 5.89 Million TWD | -41.031% |
| GeneReach Biotechnology Corp. | 257.03 Million TWD | 96.764% |
| Shine-On BioMedical Co.,Ltd. | 538 Thousand TWD | -1446.097% |
| CHO Pharma, Inc. | - TWD | -Infinity% |
| Andros Pharmaceuticals Co.,Ltd | 27.12 Million TWD | 69.33% |
| Visgeneer Inc. | 158.6 Million TWD | 94.756% |
| Greenyn Biotechnology Co., Ltd | 196.13 Million TWD | 95.759% |
| BioLASCO Taiwan Co., Ltd. | 58.2 Million TWD | 85.709% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 417.01 Million TWD | 98.005% |
| Sagittarius Life Science Corp | 13.32 Million TWD | 37.567% |
| BioGend Therapeutics Co., Ltd. | 13.09 Million TWD | 36.465% |
| GlycoNex Incorporation | 900 Thousand TWD | -824.222% |
| Medigen Biotechnology Corp. | 2.91 Billion TWD | 99.714% |
| Pharmosa Biopharm Inc. | 144.36 Million TWD | 94.238% |
| PharmaEngine, Inc. | 14.8 Million TWD | 43.831% |
| Intech Biopharm Corporation | 1.43 Billion TWD | 99.42% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 320.13 Million TWD | 97.402% |
| BiOptic Inc. | 93.19 Million TWD | 91.075% |
| TaiGen Biopharmaceuticals Holdings Limited | 74.68 Million TWD | 88.863% |
| Senhwa Biosciences, Inc. | 9.6 Million TWD | 13.363% |
| NatureWise Biotech & Medicals Corporation | 10.68 Million TWD | 22.131% |
| OBI Pharma, Inc. | 501.05 Million TWD | 98.34% |
| Savior Lifetec Corporation | 270.37 Million TWD | 96.924% |
| Great Novel Therapeutics Biotech & Medicals | 14.37 Million TWD | 42.136% |
| Level Biotechnology Inc. | 13.5 Million TWD | 38.394% |
| Medigen Vaccine Biologics Corporation | 1.97 Billion TWD | 99.579% |
| Meribank Biotech Co., Ltd | 34.03 Million TWD | 75.563% |
| Acepodia, Inc. | 273.81 Million TWD | 96.962% |
| Caliway Biopharmaceuticals Co., Ltd. | 20.45 Million TWD | 59.341% |